Recent INZY Stock Price | INZY Stock Predictions | |
$4.61 | +359.87% |
$21.20 |
Recent INZY Analyst Ratings Breakdown, Making INZY Stock Predictions | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | 5 | 5 | 5 | 6 |
Buy ratings: | 1 | 1 | 1 | 1 |
Hold ratings: | 0 | 0 | 0 | 0 |
Sell ratings: | 0 | 0 | 0 | 0 |
Strong sell ratings: | 0 | 0 | 0 | 0 |
Average rating: | 1.17 | 1.17 | 1.17 | 1.14 |
For the INZY stock predictions from the analysts covering Inozyme Pharma Inc, we have collected all of the individual INZY stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 5 different analysts covering INZY (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since INZY stock predictions may vary widely, another useful metric to consider is the median INZY stock prediction, which represents the price at which half of the analysts
made INZY stock predictions that were higher and half made INZY stock predictions that were lower. This makes for a different take on the INZY stock predictions out there, as compared to average or mean.
And that median across all the individual INZY stock predictions was: $15.0 as of 2024-05-02.
The very highest of the INZY stock predictions for one year price target was $40.0, while the very lowest of the INZY stock predictions in the analyst group was
$14.0 (with a standard deviation of $11.166). Get the latest Zacks research report on INZY — FREE
Find out: INZY next earnings date »
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
OXLC Stock Predictions
LEU Stock Predictions
HFWA Stock Predictions
IOSP Stock Predictions
XENT Stock Predictions
UMBF Stock Predictions
AVXL Stock Predictions
GPS Stock Predictions
EXP Stock Predictions
|
|
Strong Buy (3.83 out of 4) 75th percentile
(ranked higher than approx. 75% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |